Great Lakes Cancer Management Specialists

Recent papers from Great Lakes Cancer Management Specialists

1. All-cause mortality by race and socioeconomic status among women treated for breast cancer in metropolitan DetroitCancer Epidemiology · 2026
2. Influence of a community practice innovation on a statewide cancer drug repository network.JCO Oncology Practice · 2024
3. Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancerSurgical Oncology · 2022
4. Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene SignatureJCO Precision Oncology · 2022
5. Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast CancerAnnals of Surgical Oncology · 2022
6. Immunotherapy-associated autoimmune hemolytic anemiaJournal for ImmunoTherapy of Cancer · 2017
7. Modulation of deoxycytidine kinase (dCK) and glycogen synthase kinase (GSK-3β) by anti-CD20 (rituximab) and 2-chlorodeoxyadenosine (2-CdA) in human lymphoid malignanciesExperimental Hematology and Oncology · 2014